Mintz, Levin, Cohn, Ferris, Glovsky and Popeo advised Adlumin, Inc. on the transaction, while DLA Piper advised N-able, Inc. N-able, Inc. (NYSE: NABL), a global software...
N-able’s $266 Million Acquisition of Adlumin
ANI Pharmaceuticals’ Acquisition of Alimera Sciences
Hughes Hubbard & Reed advised ANI, while DLA Piper advised Alimera Sciences on the deal. Alimera Sciences, Inc., a global pharmaceutical company focused on ophthalmic solutions,...